Clinical trial
A Prospective, Multi-center, Randomized Controlled, Clinical Trial to Evaluate the Safety and Efficacy of NxiDIME™ Intracranial Drug-eluting Self-expanding Stent System
NCT07197970 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Controlled, Clinical Trial to Evaluate the Safety and Efficacy of NxiDIME™ Intracranial Drug-eluting Self-expanding Stent System
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- May 15, 2025
- Completion date
- May 15, 2027
- Enrollment
- 224 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
symptomatic intracranial atherosclerotic stenosis